XML 29 R19.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Commitments and Contingencies
6 Months Ended
Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

9. Commitments and contingencies

Lease commitments

The Company’s lease portfolio primarily comprises operating leases for office, laboratory, and manufacturing space. These leases contain various rent abatement periods, after which they require monthly lease payments that may be subject to annual increases throughout the lease term. Certain leases include options to extend the term. The renewal option is considered in the remaining lease term for the lease only when the Company is reasonably certain it will renew the lease. Certain leases provide the Company with the right to make tenant improvements, including the addition of laboratory space or build-out of manufacturing capabilities, and include a lease incentive allowance.

In June 2022, the Company entered into a lease agreement for 79,565 square feet of office, laboratory, and manufacturing space located in Bothell, Washington (the Bothell facility). The initial term of the lease expires in February 2039, with the option to extend the lease for up to three additional five-year terms. The lease agreement also provides for up to $19.9 million for reimbursement of tenant improvements, as well as an additional $8.0 million loan for tenant improvements, available at the Company’s election, which the Company would be obligated to repay to the landlord monthly over the initial term of the lease with interest at a rate of 6.5% per year (the Tenant Improvement Loan). The Company elected to receive the Tenant Improvement Loan in the second quarter of 2024. As of June 30, 2024, $0.3 million was included in accrued expenses and other current liabilities and $7.3 million was included in other non-current liabilities. The Company is obligated to pay base rent of approximately $68.8 million over the initial term of the lease. In accordance with the lease agreement, the Company has obtained a letter of credit in the amount of $1.6 million.

In April 2024, the Company amended the terms of certain agreements for its vivarium spaces in Cambridge, Massachusetts and South San Francisco, California, resulting in these agreements no longer requiring recognition on the balance sheet. In the second quarter of 2024, the Company derecognized the remaining balances related to the right-of-use asset and lease liability of $6.4 million and $6.2 million, respectively.

The following table contains additional information related to the Company’s operating leases:

 

Location

 

Use

 

Approximate
Square Footage

 

Commencement Dates

 

Expiration Dates

Seattle, WA

 

Office/Laboratory

 

48,000

 

March 2019 to September 2020

 

December 2026 to April 2028

Cambridge, MA

 

Office/Laboratory

 

56,000

 

March 2019 to January 2020

 

June 2027 to February 2028

South San Francisco, CA

 

Office/Laboratory

 

99,000

 

December 2019 to April 2022

 

April 2030

Rochester, NY

 

Office/Laboratory

 

3,000

 

January 2022

 

January 2025

Bothell, WA

 

Office/Laboratory/Manufacturing

 

80,000

 

January 2023

 

January 2039

Throughout the term of each lease agreement, the Company is responsible for paying, in addition to base rent, certain operating costs, such as common area maintenance, taxes, utilities, and insurance. These additional charges are considered variable lease costs and are recognized in the period in which the costs are incurred.

The following table summarizes the Company’s lease costs:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

Operating lease cost

 

$

4,469

 

 

$

6,981

 

 

$

9,088

 

 

$

14,042

 

Short-term lease cost

 

 

1,189

 

 

 

-

 

 

 

2,551

 

 

 

-

 

Variable lease cost

 

 

2,088

 

 

 

1,929

 

 

 

4,102

 

 

 

3,911

 

Total lease cost

 

$

7,746

 

 

$

8,910

 

 

$

15,741

 

 

$

17,953

 

As of June 30, 2024, the weighted-average remaining lease term was 9.7 years, and the weighted-average incremental borrowing rate was 11.4%.

The following table reconciles the Company’s undiscounted operating lease cash flows by fiscal year to the present value of the operating lease liabilities as of June 30, 2024 (in thousands):

 

2024 (remaining 6 months)

 

$

8,863

 

2025

 

 

21,768

 

2026

 

 

22,472

 

2027

 

 

19,899

 

2028

 

 

15,226

 

2029 and thereafter

 

 

93,495

 

Total undiscounted lease payments

 

 

181,723

 

Less: imputed interest

 

 

(83,001

)

Less: tenant improvement allowances

 

 

(165

)

Present value of operating lease liabilities

 

 

98,557

 

Less: current portion of operating lease liabilities

 

$

(9,998

)

Operating lease liabilities, net of current portion

 

$

88,559